Related Experiment Video
Updated: Jan 20, 2026
DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
Published on: February 27, 2014
Emu Oil: A Potential Adjunct to Inflammatory Bowel Disease Treatment?
Sisanda Nomcebo Mhlanga1,2, Gordon Stanley Howarth1,2,3, Suzanne Mashtoub1,2,4,5,6
1School of Biomedicine, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia.
Emu oil shows potential for treating inflammatory bowel disease (IBD) due to its anti-inflammatory properties observed in preclinical studies. Further clinical trials are needed to confirm its safety and efficacy as a complementary therapy for IBD.
Area of Science:
- Gastroenterology
- Natural Product Research
- Inflammation Biology
Background:
- Inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, is a chronic condition with limited treatment efficacy and significant side effects.
- Current therapeutic options for IBD encompass a range of medications and surgical interventions, yet relapse remains a concern for many patients.
Purpose of the Study:
- To explore the potential of emu oil (EO), a natural product, as an adjunct therapy for inflammatory bowel disease (IBD).
- To review the anti-inflammatory, antioxidant, and tissue-healing properties of emu oil based on preclinical evidence.
Main Methods:
- This is a narrative review of existing preclinical studies on orally administered emu oil (EO).
- The review focuses on the composition of emu oil and its demonstrated effects in animal models of intestinal inflammation.
Main Results:
- Preclinical trials indicate that emu oil possesses anti-inflammatory, antioxidant, and reparative properties beneficial for intestinal healing.
- Oral administration of emu oil in animal models has shown reduced inflammation and mucosal damage in various intestinal inflammatory conditions.
Conclusions:
- Emu oil exhibits promising characteristics for managing inflammatory bowel disease (IBD) based on preclinical data.
- Further rigorous clinical trials are essential to establish the safety and efficacy of emu oil as a complementary treatment for IBD.
Related Concept Videos
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:21Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
09:04DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
08:27Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...